Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay. (2026). Voprosy Onkologii, 72(2), OF-2510. https://doi.org/10.37469/0507-3758-2026-72-2-OF-2510